Literature DB >> 23779068

Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not).

Salvatore Maria Corsello, Roberto Salvatori, Agnese Barnabei, Liana De Vecchis, Paolo Marchetti, Francesco Torino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23779068     DOI： 10.1007/s00280-013-2213-y

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  9 in total

1.  Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study.

Authors:  Le Min; Frank Stephen Hodi; Anita Giobbie-Hurder; Patrick A Ott; Jason J Luke; Hilary Donahue; Meredith Davis; Rona S Carroll; Ursula B Kaiser
Journal:  Clin Cancer Res       Date:  2014-12-23       Impact factor: 12.531

Review 2.  ACR Appropriateness Criteria® pre-irradiation evaluation and management of brain metastases.

Authors:  Simon Shek-Man Lo; Elizabeth M Gore; Jeffrey D Bradley; John M Buatti; Isabelle Germano; A Paiman Ghafoori; Mark A Henderson; Gregory J A Murad; Roy A Patchell; Samir H Patel; Jared R Robbins; H Ian Robins; Andrew D Vassil; Franz J Wippold; Michael J Yunes; Gregory M M Videtic
Journal:  J Palliat Med       Date:  2014-06-27       Impact factor: 2.947

Review 3.  Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints.

Authors:  Lee-Shing Chang; Romualdo Barroso-Sousa; Sara M Tolaney; F Stephen Hodi; Ursula B Kaiser; Le Min
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

Review 4.  The side effects of immune checkpoint inhibitor therapy on the endocrine system.

Authors:  Itivrita Goyal; Manu Raj Pandey; Rajeev Sharma; Ajay Chaudhuri; Paresh Dandona
Journal:  Indian J Med Res       Date:  2021-04       Impact factor: 5.274

5.  Immune-related endocrine disorders in novel Immune checkpoint inhibition therapy.

Authors:  Le Min
Journal:  Genes Dis       Date:  2016-10-26

6.  Case Report: Ipilimumab-Induced Panhypophysitis: An Infrequent Occurrence and Literature Review.

Authors:  Agnese Barnabei; Silvia Carpano; Alfonsina Chiefari; Marta Bianchini; Rosa Lauretta; Marilda Mormando; Guilia Puliani; Giancarlo Paoletti; Marialuisa Appetecchia; Francesco Torino
Journal:  Front Oncol       Date:  2020-12-01       Impact factor: 6.244

Review 7.  Endocrine Toxicities of Antineoplastic Therapy: The Adrenal Topic.

Authors:  Agnese Barnabei; Paola Senes; Alessandro Scoppola; Alfonsina Chiefari; Giovanni Maria Iannantuono; Marialuisa Appetecchia; Francesco Torino
Journal:  Cancers (Basel)       Date:  2022-01-25       Impact factor: 6.639

Review 8.  Immune Checkpoint Inhibitor-Induced Central Diabetes Insipidus: Looking for the Needle in the Haystack or a Very Rare Side-Effect to Promptly Diagnose?

Authors:  Agnese Barnabei; Lidia Strigari; Andrea Corsello; Rosa Maria Paragliola; Luca Falzone; Roberto Salvatori; Salvatore Maria Corsello; Francesco Torino
Journal:  Front Oncol       Date:  2022-03-03       Impact factor: 6.244

9.  Nivolumab Induced Thyroid Dysfunction: Unusual Clinical Presentation and Challenging Diagnosis.

Authors:  Carmine Iadarola; Laura Croce; Erica Quaquarini; Cristina Teragni; Sara Pinto; Antonio Bernardo; Rodolfo Fonte; Michele Marinò; Mario Rotondi; Luca Chiovato
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-17       Impact factor: 5.555
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.